Regeneron Pharmaceuticals
REGN
#270
Rank
NZ$141.35 B
Marketcap
NZ$1,334
Share price
2.57%
Change (1 day)
7.86%
Change (1 year)

Earnings for Regeneron Pharmaceuticals (REGN)

Earnings in 2025 (TTM): NZ$8.82 Billion

According to Regeneron Pharmaceuticals's latest financial reports the company's current earnings are NZ$14.24 Billion. In 2024 the company made an earning of NZ$8.30 Billion, an increase over its 2023 earnings that were of NZ$7.29 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Regeneron Pharmaceuticals from 1990 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) NZ$8.82 B6.37%
2024 NZ$8.30 B13.83%
2023 NZ$7.29 B-13.57%
2022 NZ$8.43 B-47.9%
2021 NZ$16.19 B144.75%
2020 NZ$6.61 B56.86%
2019 NZ$4.21 B-4.87%
2018 NZ$4.43 B22.86%
2017 NZ$3.60 B56.3%
2016 NZ$2.30 B8.55%
2015 NZ$2.12 B54.53%
2014 NZ$1.37 B11.14%
2013 NZ$1.23 B72.13%
2012 NZ$0.71 B-285.93%
2011 -NZ$0.39 Billion121.73%
2010 -NZ$0.18 Billion37.18%
2009 -NZ$0.13 Billion-14.6%
2008 -NZ$0.15 Billion-25.02%
2007 -NZ$0.2 Billion6.32%
2006 -NZ$0.19 Billion-186.52%
2005 NZ$0.21 B2103.7%
2004 NZ$9.8 M-105.66%
2003 -NZ$0.18 Billion-18.18%
2002 -NZ$0.22 Billion42.33%
2001 -NZ$0.15 Billion129.35%
2000 -NZ$64.89 Million51.87%
1999 -NZ$42.73 Million92.19%
1998 -NZ$22.23 Million66.23%
1997 -NZ$13.38 Million-55.49%
1996 -NZ$30.05 Million103.53%
1995 -NZ$14.77 Million-70.89%
1994 -NZ$50.72 Million-26.08%
1993 -NZ$68.6 Million114.67%
1992 -NZ$31.96 Million196.77%
1991 -NZ$10.77 Million87.88%
1990 -NZ$5.74 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
NZ$14.31 B 60.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
NZ$0.22 B-97.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$3.30 B-62.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$56.26 B 529.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$28.51 B 219.12%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
NZ$15.80 B 76.87%๐Ÿ‡ซ๐Ÿ‡ท France